Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.

Kuo CH, Lin YL, Tang CC, Hsu BG

Open source

DOI
10.4103/tcmj.tcmj_192_25
Published
2026 Jan-Mar
Container
Tzu chi medical journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/tcmj.tcmj_192_25,
  title = {Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.},
  author = {Kuo CH and Lin YL and Tang CC and Hsu BG},
  year = {2026},
  journal = {Tzu chi medical journal},
  doi = {10.4103/tcmj.tcmj_192_25},
  url = {https://doi.org/10.4103/tcmj.tcmj_192_25}
}

RIS

TY  - JOUR
TI  - Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.
AU  - Kuo CH
AU  - Lin YL
AU  - Tang CC
AU  - Hsu BG
PY  - 2026
JO  - Tzu chi medical journal
DO  - 10.4103/tcmj.tcmj_192_25
UR  - https://doi.org/10.4103/tcmj.tcmj_192_25
ER  - 

APA

CH, K., YL, L., CC, T., & BG, H. (2026). Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.. Tzu chi medical journal. https://doi.org/10.4103/tcmj.tcmj_192_25

Source records